当前位置:首页 >财报库 > 报告详情

吉利德科学Gilead Sciences(GILD)2022年ESG报告「NASDAQ」(英文版)(149页).pdf

上传人: Kell****reet 编号:653880 2023-05-20 149页 14.25MB

下载:

1、ENVIRONMENTAL SOCIAL GOVERNANCE IMPACT REPORT2022Greg Klak Vice President,Operations and General Manager,Gilead AlbertaRoderick Mack Financial Assistant,FinanceAna Gonzalez Director,Medicinal ChemistryNicole Kho Director,SustainabilityCREATING POSSIBLEINNOVATING FOR UNMET NEEDSEMPOWERING PEOPLE AND

2、COMMUNITIESSUSTAINING OUR SHARED PLANET2134 4681258 60 71 76 77808991 103 Scientific Innovation Health Equity Access and Affordability About Gilead ESG at Gilead Engaging and Empowering Employees Inclusion and Diversity Recruitment and Retention Workplace Safety Employee Data The Larger Gilead Commu

3、nity Sustainability Targets Environmental Action Advancing Sustainability Beyond Gilead1234E N V I R O N M E N T A L S O C I A L G O V E R N A N C E I M PA C T R E P O R T|2 0 2 2 Forward-Looking StatementsStatements included in this 2022 ESG report that are not historical in nature are forward-look

4、ing statements within the meaning of the Private Securities Litigation Reform Act of 1995.Gilead cautions readers that forward-looking statements are subject to certain risks and uncertainties are identified from time to time in Gileads reports when filed with the SEC,including annual reports on For

5、m-10-K,quarterly reports on Form 10-Q and current reports on Form 8-K.All forward-looking statements are based on information currently available to Gilead,and Gilead assumes no obligation to update or supplement any such forward-looking statements other than as required by law.Any forward-looking s

6、tatements speak only as of the date hereof or as of the dates indicated in the statements.3Vivian Barry Pathobiology I N N O V AT I N GE M P O W E R I N GS U S TA I N I N GR E P O R T I N GC R E A T I N G4 To All Stakeholders:Thank you for your interest in Gilead and our ESG commitments.We hope that

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要介绍了Gilead公司在环境、社会和治理(ESG)方面的表现和承诺。Gilead公司致力于通过创新药物的研发和推广,改善全球健康不平等状况,并推动环境可持续发展。 关键点包括: 1. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。 2. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。 3. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。 4. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。 5. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。 6. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。 7. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。 8. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。 9. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。 10. Gilead公司通过其药物研发,为全球数百万患者提供了治疗,包括HIV、病毒性肝炎和癌症等疾病。
Gilead如何通过ESG战略实现可持续发展? Gilead在提高药物可及性方面有哪些创新举措? Gilead如何通过科学创新推动健康公平?
客服
商务合作
小程序
服务号
折叠